Holocene Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Holocene Advisors's VKTX Position: Q3 2026 in Review
Holocene Advisors opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 133,542 shares worth $4.35M. The stake represents 0.01% of the portfolio and ranks #352 among its holdings.
444 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Holocene Advisors held 133,542 shares of Viking Therapeutics worth $4.35M as of Q3 2026.
- Viking Therapeutics was a new Holocene Advisors position in Q3 2026.
- Viking Therapeutics made up 0.01% of Holocene Advisors's portfolio in Q3 2026, its #352 holding.
- 444 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Holocene Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.